GASAR Study

“Genetic Assessment and Surveillance of Antibiotic Resistance Study”

Step up with GASAR. Contribute to a repository that's reshaping India's approach to the threat of antimicrobial resistance.

The GASAR Study aims to address the growing concern of antibiotic resistance in India, among critical priority gram-negative pathogens identified by the World Health Organization (WHO). This initiative involves collecting and analysing the multi drug resistant gram-negative bacterial isolates from various hospitals across different geographical locations of India, with the primary goal of providing comprehensive information about the resistant genes present within these pathogens. To become India's largest surveillance program along the likes of SENTRY and ATLAS

Express Interest

Why GASAR?

Why GASAR?

Antimicrobial Resistance directly lead to killing at least 1.27 million people worldwide and associated with nearly 5 million deaths in 2019: THE LANCET


In India in 2019, there were 297,000 deaths attributable to AMR and 1 Million deaths associated with AMR: IHME


Recognizing that antimicrobial resistance can vary significantly from region to region, focusing on resistance data from Indian hospitals across regional geographies, GASAR study is expected to help the clinicians tailor their efforts to the specific challenges faced in the region.


Study approach goes beyond traditional resistance data collection. It delves into the genetic characteristics of pathogens. This means microbiologists will not only identify which antibiotics are effective or not but also gain insights into the genetic mechanisms driving resistance. This level of detail enables a more nuanced understanding of resistance patterns and paves the way for more targeted treatment strategies..

Few of the benefits offered by GASAR study are:

  • AMR Epidemiology.

    GASAR isn't just about data collection, it's a research initiative. By participating in GASAR, microbiologists have the opportunity to contribute to cutting-edge research in the field of antimicrobial resistance. Their work will directly contribute to advancements in understanding deeper aspects of resistance mechanisms, which is crucial for developing new treatments and strategies.

  • Nurturing Collaboration among Institutions & experts.

    The initiative aims to bring together experts from different regions and hospitals, creating a network of knowledge-sharing and collaboration that can strengthen the collective response to antimicrobial resistance.

  • India centric AMR database.

    By focusing on genotypical characterization from isolates collected across India. GASAR can contribute valuable insights to the global effort to combat resistance, highlighting our commitment to global health.

  • Impact on Patient Care.

    Genotypical characterization of hospital isolates is expected to have a direct impact on patient care. By understanding the genetic makeup of these pathogens, healthcare providers can make more informed decisions about which antibiotics to use, reducing the risk of ineffective treatments and improving patient outcomes.

  • Long-term Solutions:

    Key expectation from GASAR study is about finding sustainable, long-term solutions to the antimicrobial resistance problem in India. It's not just about reacting to resistance but understanding it at its core and developing strategies to mitigate it effectively.

  • AMR Epidemiology.

    GASAR isn't just about data collection, it's a research initiative. By participating in GASAR, microbiologists have the opportunity to contribute to cutting-edge research in the field of antimicrobial resistance. Their work will directly contribute to advancements in understanding deeper aspects of resistance mechanisms, which is crucial for developing new treatments and strategies.

  • Nurturing Collaboration among Institutions & experts.

    The initiative aims to bring together experts from different regions and hospitals, creating a network of knowledge-sharing and collaboration that can strengthen the collective response to antimicrobial resistance.

  • India centric AMR database.

    By focusing on genotypical characterization from isolates collected across India. GASAR can contribute valuable insights to the global effort to combat resistance, highlighting our commitment to global health.

  • Impact on Patient Care.

    Genotypical characterization of hospital isolates is expected to have a direct impact on patient care. By understanding the genetic makeup of these pathogens, healthcare providers can make more informed decisions about which antibiotics to use, reducing the risk of ineffective treatments and improving patient outcomes.

  • Long-term Solutions:

    Key expectation from GASAR study is about finding sustainable, long-term solutions to the antimicrobial resistance problem in India. It's not just about reacting to resistance but understanding it at its core and developing strategies to mitigate it effectively.

The GASAR Kit

A three-part packaging system for isolate transportation. This kit includes: a main container to accommodate slant racks and an absorbent component to contain any potential liquid spills; a secondary container that is leak-resistant; and a sturdy external box. The collection of isolates will be solely handled by logistics providers sanctioned by GASAR, who have expertise in managing biological and infectious materials, thereby ensuring adherence to the WHO's 'Regulations for the Transportation of Infectious Substances 2021-2022' guidelines.

© PLEA Trust 2024 | All rights reserved

© PLEA Trust 2024 | All rights reserved

© PLEA Trust 2024 | All rights reserved